Objectives. Patients with FM are heterogeneous. They present with a variety of pain qualities, sensory abnormalities and additional comorbidities. The aim was to identify clinically distinguishable subgroups of patients.
Introduction
FM is a complex, heterogeneous disease entity with limited treatment options characterized by persistent widespread pain, abnormal pain sensitivity and additional symptoms, such as fatigue and sleep disturbance. Despite intensive research, major gaps in our understanding of the pathogenesis and aetiology of FM still remain. The definition is based on the ACR classification scheme. To fulfil these criteria, the patient is required to have a history of chronic widespread pain and the finding of at least 11 of 18 possible tender points on examination [1] . With this definition, the prevalence of FM ranges from 0.5 to 4% [2] . In general, FM is regarded as a disease that predominantly affects the muscular-skeletal system. But besides spontaneous pain in the muscles or joints, most individuals describe a variety of sensory symptoms. These include prickling sensations, pain attacks and cutaneous hyperalgesia [3] [4] [5] . The skin might be sensitive to thermal or mechanical stimuli [6] . Apart from these sensory abnormalities, the patients often suffer from a variety of comorbidities, such as anxiety, sleep disorders or depression [7, 8] . Given this heterogeneity of the clinical manifestation, it is likely that FM is not a discrete aetiological entity, but rather a conglomerate of many overlapping syndromes and symptoms. Thus, it seems necessary to identify subgroups of patients who have specific clinical phenotypes in common, ideally using measures that would help to tailor more specific therapies for the individual patient.
Previous attempts to identify subgroups of FM patients used either psychosocial and cognitive characteristics [9] or a combination of sensory assessment measures (i.e. pressure pain thresholds) and psychological factors [10] . In one study, it was in fact shown that subgroups respond differently to psychological treatment approaches [11] . In addition to psychosocial and cognitive factors, however, increasing evidence suggests important neurobiological factors underlying the aetiology of FM. Several techniques have been used to unravel potential pathophysiological mechanisms of nociceptive processing. According to the central disinhibition theory, quantitative sensory testing demonstrated decreased detection thresholds for cold and heat stimuli [12] [13] [14] , as well as enhanced noxious percepts to repetitive nociceptive stimuli, i.e. temporal or spatial summation [15, 16] . Imaging studies revealed an abnormal processing of sensory stimuli in various parts of the central pain matrix and, in particular, a decreased activity in inhibitory brain centres [17, 18] . Taking these data together, FM is very likely associated with a hyperexcitable state of the CNS.
Patients with neuropathic pain syndromes show several similarities to FM. First, the affected skin is often very tender to external thermal and mechanical stimuli. Secondly, central sensitization of nociceptive neurons and attenuation of inhibitory control systems are also discussed to be fundamental mechanisms underlying the generation of neuropathic pain. These similarities suggest that at least some of the sensory complaints of FM patients are based on mechanisms that are similar to those operating in neuropathic pain. Despite the fact that these sensory symptoms are often described by FM patients and also commented on in the literature, there is to our knowledge so far no study that has evaluated the frequency and distribution of these symptoms. In order to assess the abnormalities of sensory function in a standardized way and in a large cohort of FM patients, we used an instrument that was originally developed and validated to detect sensory symptoms of neuropathic pain patients, i.e. the painDETECT questionnaire.
The present investigation uses epidemiological and clinical data on the symptomatology of 3035 patients with FM, which were collected within a cross-sectional cohort survey in Germany (painDETECT) performed in collaboration with the German Research Network on Neuropathic Pain (DFNS). The aims were: (i) to describe characteristic epidemiological data and comorbidities; and (ii) to detect subgroups of patients with typical clinical profiles, i.e. typical constellations and combinations of sensory symptoms and comorbidities.
Methods

Study population and data collection
The study was performed at 220 outpatient centres throughout Germany, including those of general practitioners, rheumatologists, orthopaedists and pain specialists. Patients presenting with FM confirmed according to the ACR criteria, and who were at least 18 years old, were given a hand-held computer (personal digital assistants, PDAs; Palm Tungsten E operating on the platform OS 5.4) and requested to complete the questionnaires for the epidemiological and clinical survey electronically. This method of data acquisition was validated in an earlier study [19] . The sites were responsible for the correct implementation of study procedures; thus, centrally organized monitoring was not performed. The programming included automated plausibility checks. At intervals, PDAs were collected, and data transfer and processing were performed under secure conditions, with anonymization and encryption. Physicians did not receive a financial incentive for taking part in the epidemiological study. The study was approved by the ethical committee of the University of Dü sseldorf, and all participating patients gave written informed consent according to the Declaration of Helsinki.
Questionnaires
In addition to standard demographical questions, the following questionnaires were used to assess comorbidities and pain symptoms: for sleep disturbances, the Medical Outcomes Study (MOS) sleep scale [20] ; for depressive disorders, and panic and anxiety disorders, the Germanlanguage Patient Health Questionnaire (PHQ) [21] ; and for sensory symptoms, the painDETECT questionnaire [22] . From the latter, seven questions regarding the severity and quality of the patient's pain were analysed. The patients could rate the perceived severity of each of these symptoms from 0 to 5 (0: never; 1: hardly noticed; 2: slightly; 3: moderately; 4: strongly; and 5: very strongly). The patients were asked to describe the symptoms associated with FM. Furthermore, the patients marked their pain locations on a schematic body drawing. The questions addressed the sensations within the most painful body area: Question 1: spontaneous burning pain; Question 2: spontaneous prickling sensations; Question 3: pain evoked by light touch (allodynia); Question 4: spontaneous pain attacks; Question 5: pain evoked by thermal stimuli; Question 6: numbness; and Question 7: pressure pain. All questionnaires are validated and in common use.
www.rheumatology.oxfordjournals.org Statistics Descriptive statistical analyses were performed with the SAS package, version 9.2 (SAS Institute Inc., Cary, USA). The t-test, with estimation of variances according to Satterthwaite's method, was used to evaluate differences in continuous variables between the two groups of patients. Continuous variables were presented within tables by mean (S.D.). Categorical data were tabulated using frequencies and percentages.
In order to identify relevant subgroups of patients who are characterized by a typical constellation of symptoms and comorbidities, a hierarchical cluster analysis was performed. In order to eliminate inter-individual differences of the general perception of sensory stimuli (differences in individual pain perception thresholds), the intensity scores of the questions were re-calculated for the cluster analysis. In detail, the given 0-5 score of each question was subtracted from the mean of all values marked in seven questions. In this individual score, values >0 indicate a sensation that is more intensive than the individual mean pain perception, and values <0 indicate a sensation that is less intensive than the individual mean pain perception. In addition to the sensory symptoms, the depression (PHQ-9) and sleep scores (MOS) were also included into the clustering process.
We used the hierarchical Ward approach with a squared Euclidean distance measure. As there are no objective and compelling rules for determination of an optimal cluster number, we used three criteria: the development of values of the Ward fusion algorithm with respect to cluster numbers; practical decisions about minimal group numbers; and decisions about sense of combining groups as regards content. To provide evidence of the result, a kmeans analysis was performed on the basis of these results. The clusters are represented by the patterns of questionnaire scores, thus showing the typical pathological structure of the respective group. Heuristic interpretations of the clusters were given by experts. As this is a heuristic approach, no statistical analysis was performed.
Results
Epidemiological data and comorbidities A total of 3035 FM patients took part in the survey. The demographical profile and presence of comorbidities are shown in Table 1 . On the PHQ-9 scale for depression, scores were rated as follows: 0-4 (none); 5-9 (mild); 10-14 (moderate); 15-19 (moderately severe); and 20-27 (severe). As shown in Table 1 , moderate to severe comorbid depression occurred in 66% of the patients. The MOS sleep questionnaire was evaluated such as to record for each patient 'optimal sleep', 'sleep disturbance', 'somnolence', 'sleep quantity' and 'sleep adequacy'. Only 30% of the patients had optimal sleep. About 13% of the entire FM cohort was male. These 381 male patients were on average slightly younger than the female patients.
Pain intensity, quality and location. The visual analogue scale (VAS) intensity values were on average: for 'worst pain' 8.1 (1.7); for 'average pain' 6.4 (1.9); and for 'current pain' 5.9 (2.3). Seven questions of the painDETECT questionnaire address the quality and intensity of specific pain symptoms. In Table 2 , the frequency of the clinically relevant sensory disturbances (i.e. if the patients marked a score of >3, strongly, very strongly) is shown for each of the seven questions. Pressure pain was rated in 58.3% of the patients as clinically relevant, followed by prickling sensations (32.6%), burning pain (29.8%), thermal hypersensitivity (24.0%), allodynia (20.4%) and numbness (19.8%). Severe pain attacks were indicated by 39.9% of the patients.
Subgroups of patients with characteristic clinical profiles. In addition to the characteristic distribution of each of the sensory symptoms, the patients also showed typical combinations of symptoms and comorbidities. A cluster analysis was performed to identify relevant subgroups of patients who presented with a characteristic clinical profile. A cut-off point for essential clusters with respect to practical considerations was set at 15% of all evaluated cases. We decided to include five clusters, since a result that incorporated fewer clusters would lack important differences by the agglomeration process. In addition, a result with five essential clusters gained by the hierarchical Ward clustering is an optimal agreement regarding our decision criteria. Performing a follow-up k-means clustering based on the five-cluster solution for means of control, to allow cases to be reorganized, led to an equivalent result that supported our chosen result. All sensory profiles are given as individual adjusted scores (see above). Table 3 and Fig. 1 show different clusters with distinct clinical profiles. In the five-cluster solution, we found profiles with remarkable differences in the expression of clinical symptoms.
Subgroup 1, for example, is characterized by severe thermal hypersensitivity, whereas in Subgroup 4 painful attacks dominate the clinical picture. In Subgroup 3, pressure-induced pain is prominent whereas all other sensory symptoms are only moderately perceived. Interestingly, this subgroup is characterized by the lowest depression and sleep disturbance scores (PHQ-9 8.0, MOS 36.5). Also noticeable is Subgroup 5: all sensory disturbances are only moderately expressed and show little variance (all values are grouped around the 0 axis). Patients in this particular subgroup suffer from the highest depression scores (PHQ-9: 18.3), higher than in all other subgroups.
Discussion
The clinical phenotype of FM, i.e. the different pain qualities and locations, the various combinations of sensory abnormalities and the constellations of comorbidities, are very heterogeneous and differ between each individual patient. Several interacting factors, including epidemiological, psychosocial, environmental and pathophysiological components influence the patient's individual clinical picture.
Increasing knowledge about how these individual clinical pictures are generated is as important for a better understanding and acceptance of the disease as it is for the improvement of treatment strategies, which are still limited. This cross-sectional survey provides data on the clinical picture, sensory characteristics and typical patterns of potential comorbidities of a large cohort of FM patients.
An interesting finding of the study is that there is a high correlation between depressive symptoms and sleep disturbances (Table 3 and Fig. 1 ). It might be assumed that the sleep disturbances described by the patients are in part owed to the depressive comorbidity [8] .
Patterns of sensory pain symptoms
Pain intensity, quality and location. It is important to know which sensory symptoms are clinically relevant as perceived by the patients themselves. Therefore, 'PatientReported Outcomes' (PROs) that collect health-related data directly from the patients are increasingly used in clinical research [23] . In the present study, the frequency of clinically relevant sensory disturbances, i.e. the patients who replied to the questions with a score of >3 (strongly, very strongly), was calculated ( Table 2 ). The most frequent sensory symptom in FM is pressure-induced pain. However, despite the fact that all patients fulfilled the ACR criteria, only 58.3% of the patients described their pressure pain as strong or very strong. This finding is somewhat unexpected, but clearly shows that pressure Mean (S.D.). a VAS, VAS (0-100).
www.rheumatology.oxfordjournals. org FIG. 1 Subgroups of patients based on sensory symptoms and comorbidities. To identify relevant subgroups of patients who are characterized by a characteristic symptom constellation, a hierarchical cluster analysis was performed. The clusters are represented by the patterns of questionnaire scores (adjusted individual mean), thus showing the typical pathological structure of the respecting group. By using this approach, five clusters with distinct symptom profiles could be detected. Sensory profiles show remarkable differences in the expression of the symptoms. %: frequency of occurrence. pain is only one part of the entire clinical picture of FM. In fact, for a subgroup of patients pressure pain is obviously not the most disabling symptom. The next most common sensory symptom is a painful sensation that occurs during attacks. Most patients describe these attacks as follows: slight movements of the affected musculature are capable of inducing a very severe, short-lasting pain that ceases after seconds. Some patients also describe that these attacks occur at rest.
The high frequency of severe prickling sensations in one-third of the FM patients is intriguing. Prickling or ant-crawling are prominent features of polyneuropathies. However, the latter patients mainly perceive their discomfort within the skin. In contrast, patients with FM locate the prickling in deeper structures, in particular in the muscles.
Another interesting finding is the relative high incidence of touch-evoked allodynia [5] . Allodynia is thought to be induced by a gating process of information in touch-sensitive cutaneous A-beta fibres on nociceptive second-order neurons in the CNS. Thus, allodynia might be explained by a convergent afferent input of deep somatic and skin nerves on centrally sensitized nociceptive neurons [24] .
Prickling, painful attacks and allodynia are very common descriptors that are also used by neuropathic patients. Although in FM patients no nerve lesions are detectable, the similarity of sensory perceptions might indicate, in part, similar underlying mechanisms of symptom generation.
Subgroups of patients with characteristic clinical profiles
The cluster analysis revealed five distinct subgroups of patients that show a characteristic clinical profile, i.e. a typical constellation and combination of sensory symptoms, pain qualities and comorbidities (Table 3 and Fig. 1 ). All these subgroups occur in relevant numbers.
The prominent feature in Subgroup 1 is a hypersensitivity to thermal stimuli. This subgroup comprises 16.4% of all FM patients. FM patients frequently describe that their overall pain is enhanced when in contact with cold or warm environmental temperature. It is very likely that a central phenomenon eventually involving the sympathetic nervous system might underlie the temperature sensitivity in FM. A somewhat unexpected finding is that in a large subgroup of FM patients (21.3% of the entire cohort), thermal pain and mechanical sensitivity is nearly absent (Subgroup 2). The dominant complaints of this group are moderate to strong prickling sensations (see above). The relevant symptom of patients who fall into Subgroup 3 (19.8% of patients) is severe pressure pain in combination with moderate touch-evoked pain. This characteristic symptom constellation might involve a pathological sensitization of nociceptive afferents innervating deep somatic structures, which drive secondary central processes, i.e. central sensitization. Depressive symptoms and sleep disturbances are only very mildly present. Similar to these results, Giesecke et al. [10] found a subgroup of patients who exhibit extreme tenderness but lack any associated psychological/cognitive factors. The dominant symptoms of Subgroup 4 are severe and clinically relevant pain attacks and strong pressure pain. This symptom constellation occurs in 17.2% of the patients. In Subgroup 5 (25.2%), the values of the sensory profile are mainly concentrated around the zero line for all parameters without much variance. Since we used an adjusted individual score, this profile indicates that the patients tend to mark a similar score for all the questions. For example, patients who mark all questions with a score of 5 (very strongly) as well as patient who mark all questions with a score of 1 (slightly) fall into this category. These patients might be, for whatever reason, unable to discriminate between the different sensory abnormalities and, thus, answer all questions equally. This observation is particularly interesting since this group demonstrates the highest levels of depression and sleep disturbances. One might speculate that the clustering process revealed one subgroup in which comorbidities like depression and sleep disturbance dominate the clinical picture rather than sensory abnormalities. The remaining patients (Subgroups 1-4, 75%) all show severe sensory abnormalities to various degrees and combinations but only suffer mildly to moderately from comorbidities. Alternatively, it might be possible that severe comorbidities influence the perception of or the ability to discriminate between various sensory phenomena. Recent studies, however, suggest that sensory processing is not disturbed in depressed patients [25] .
In summary, the results of this study indicate that FM patients can be classified on the basis of their sensory symptoms and comorbidities by the use of a patientreported questionnaire. Four subgroups of patients suffer from various severe sensory disturbances, but lack pronounced comorbidities. In one subgroup, severe comorbidities dominate the clinical picture. These results might have implications for the understanding of the disease, future research strategies and the design of clinical trials. Subgrouping of patients with FM may be used in the future to tailor optimal treatment strategies for the appropriate patient.
Rheumatology key messages
. FM patients can be classified based on sensory symptoms and comorbidities, which have implications for future research and treatment. . Many patients have severe sensory disturbances, whereas in some comorbidities dominate.
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